Abstract

For U937 monoblasts treated for 24, 48, 96 hr with 12-0-tetradecanoyl- phorbol-13-acetate (lOrLM), there were some changes on the mean number of receptor binding site/cell and Kd, but this difference was not significant.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BD003007-01
Application #
3811200
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost